*Benchalak Maneeton¹, Prapinpatch Maneeton², Yanisa Winichaikul³, Suttipong Kawilapat¹, Nongluck Kienngam⁴, Narong Maneeton¹ (1. Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand, 2. Chiang Mai University Demonstration School, Faculty of Education, Chiang Mai University, Chiang Mai 50200, Thailand, 3. Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., 4. Department of Education Psychology and Guidance Program, Faculty of Education Chiang Mai University, Chiang Mai 50200, Thailand)

*Agata Dzwonek¹, Martin Campbell¹ (1. University of Ottawa)

*Tomoyasu Wakuda¹, Seico Benner^1,2, Yukari Uemura³, Masaki Kojima⁴, Yosuke Kameno^1,5, Hitoshi Kuwabara^1,5, Hidenori Yamasue^1,5, +32 co-authors⁶ (1. Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan, 2. Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Ibaraki, Japan, 3. Biostatistics Section, Department of Data Science, Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan, 4. Department of Child Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 5. Department of Child Development, United Graduate School of Child Development at Hamamatsu, Shizuoka, Japan, 6. University Hospitals in Japan)

*Yi-Chun Liu^1,2,3, Yin-To Liao, Vincent chin-hong Chen, Yi-Lung Chen (1. Department of Healthcare Administration, Asia University, Taichung, Taiwan, 2. Department of psychiatry, Changhua Christian Hospital, Changhua, Taiwan, 3. Department of psychiatry, Changhua Christian Children's Hospital, Changhua, Taiwan)

*Hanyong Jung¹, Jeewon Lee¹ (1. SOONCHUNHYANG UNIVERSITY BUCHEON HOSPITAL)

*Kohei Kitagawa¹, Tomoya Takemoto¹, Kaoru Seiriki¹, Atsushi Kasai^1,2, Hitoshi Hashimoto^1,3,4,5,6, Takanobu Nakazawa⁷ (1. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 2. Systems Brain Science Project, Drug Innovation Center, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 3. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Japan, 4. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 5. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 6. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan, 7. Department of Bioscience, Faculty of Bioscience, Tokyo University of Agriculture, Tokyo, Japan)

*Yoko Nawata¹, Tsuyoshi Nishioku¹, Taku Yamaguchi² (1. Department of Pharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan, 2. Department of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan)

*Satomi Matsuoka¹, Yuka Moriya¹, Fuyuka Ito¹, Mai Miyachi¹, Takemi Fuwa², Hitomi Kurahashi², Toshitaka Nabeshima^2,3, Akihiro Mouri^2,3, Yoichi Hasegawa¹ (1. Meijo University, 2. Fujita Health University Graduate School of Health Science, 3. Japanese Drug Organization of Appropriate Use and Research)

*Mao Suzuki^1,2, Nobuhiro Nakai¹, Noriko Osumi², Toru Takumi¹ (1. Kobe University School of Medicine, 2. Tohoku University Graduate School of Medicine)

*Yi-Ting Pan¹, Chi-Chun Wu³, Ming-Chai Chu³, Chen-Jiun Yeh¹, Dishary Sharmin⁴, James Cook⁴, Hui-Ching Lin³, Lih-Chu Chiou^1,2 (1. Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, 2. Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan, 3. Department and Institute of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, 4. Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA)

*Tetsuya Sasaki¹, Sara Kamiya¹, Kyoko Kishi¹, Suguru Iwata¹, Yosuke Takei¹ (1. University of Tsukuba)

*Hiroko Kotajima¹, Atsushi Sato¹, Shinya Kasai², Yoko Hagino¹, Miho Tanaka³, Yukio Takamatsu⁴, Yoshimasa Nishito⁴, Shigeo Uchino⁵, Kazutaka Ikeda¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Japan, 2. Department of Biotechnology, Center for Advanced Assisted Reproductive Technologies, University of Yamanashi, Japan, 3. Department of Psychiatry, The University of Tokyo Hospital, Japan, 4. Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Japan, 5. Department of Biosciences, School of Science and Engineering, Teikyo University, Japan)

*Shuntaro Matsushima¹, Daiki Nasukawa¹, Kota Yamada², Haruka Hirakata¹, Ryuto Tamura¹, Saya Yatagai¹, Kazuko Hayashi¹, Yusuke Ujihara³, Koji Toda¹ (1. Keio University , 2. The University of Tokyo, 3. University of Tennessee Health Science Center)

Chia-Wei Liou^1,2, Sin-Jhong Cheng³, Tzu-Hsuan Yao^1,2, Tzu-Ting Lai^1,2, Yu-Hsuan Tsai^1,2, *Wei-Li Wu^1,2 (1. Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 2. Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan)

*Tobias Patrick Whelan^1,2, Lucas G.S. Franca ^1,3, Mihail Dimitrov ¹, Naoise Mulcrone ¹, Nicolaas A. Puts^1,4, Eileen Daly ¹, Declan G.M. Murphy^1,4, Grainne M. McAlonan^1,4 (1. Dept. of Forensic & Neurodevelopmental Sciences, King's College London, , 2. COMPASS Pathfinder Ltd. , 3. Dept. of Computer & Information Sciences, Northumbria University , 4. NIHR-Maudsley Biomedical Research Centre at Maudsley NHS Foundation Trust & King's College London )

Asim Ahmed¹, Abdulrahman Abushaibah¹, Kyle Mayr¹, Veronica Rasheva¹, MoonYoung Bae¹, Patrick Whelan¹, Kartikeya Murari¹, *Ning Cheng¹ (1. University of Calgary)

*Shotaro Kawano¹, Toshihiko Kuriu², Sayaka Katayama¹, Manaka Otomo¹, Daiki Miura¹, Hotaka Fukushima¹, Kazuhiro Takuma³, Fumihito Ono⁴, Hitoshi Hashimoto^5,6,7,8,9,10, Ryota Hashimoto⁶, Takanobu Nakazawa^1,6 (1. Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan, 2. Osaka Medical and Pharmaceutical University, Research and Development Center, Osaka, Japan, 3. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka, Japan, 4. Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan, 5. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 6. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 7. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Japan, 8. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 9. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 10. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan)